The Global Fund to Fight AIDS, Tuberculosis and Malaria

The Global Fund to Fight AIDS, Tuberculosis and Malaria, commonly known as the Global Fund, is an international financing partnership established in 2002 to accelerate the response to three major infectious diseases: HIV/AIDS, tuberculosis and malaria. It operates as a grant-making institution rather than a conventional commercial bank, channeling contributions from governments, private foundations, companies, civil-society organizations and other partners into programs implemented in countries most heavily affected by the diseases. The organization’s central model is to raise money through periodic replenishment efforts and invest those resources in national and regional programs. Its work supports prevention, testing, diagnosis, treatment, care, community-led responses, health-product procurement, disease surveillance, laboratories, supply chains and other components of public-health delivery. The Global Fund also emphasizes the structural inequalities that increase exposure to disease and limit access to care, including poverty, stigma, discrimination and gender-related barriers. The partnership describes itself as the world’s largest multilateral funder of global health grants in low- and middle-income countries. It states that it raises and invests more than US$4 billion each year and works in more than 100 of the hardest-hit countries. Funding is generally implemented through country-led mechanisms and partnerships involving governments, civil-society groups, communities affected by the diseases, technical agencies and private-sector organizations. This approach is intended to align grants with national priorities while giving affected communities a formal role in planning and oversight. In addition to disease-specific activities, the Global Fund supports resilient and sustainable systems for health. These investments can include laboratories, data systems, health-workforce capacity, procurement and supply-chain infrastructure, and preparedness capabilities that benefit responses beyond AIDS, tuberculosis and malaria. The organization therefore occupies an intersection between global health philanthropy, development finance and international public-sector cooperation. Its resources are not presented as commercial products or equity investments. Instead, the organization’s principal offerings are grants, technical and implementation support, procurement arrangements and partnership platforms. The Global Fund’s positioning combines measurable disease outcomes with a broader goal of building a healthier, safer and more equitable future. Its work is carried out through a worldwide partnership, while its institutional headquarters are in Geneva, Switzerland.

The Global Fund was established in 2002 as an international response to the continuing global burden of AIDS, tuberculosis and malaria. From its inception, it was designed as a financing partnership rather than a traditional aid agency or commercial financial institution. Its purpose was to mobilize substantial resources from multiple sectors and direct them toward programs in countries where the three diseases caused the greatest harm. The organization’s operating model places countries and affected communities at the center of grant development and implementation. National stakeholders work through country coordinating mechanisms and related structures to identify priorities, prepare funding requests and oversee implementation. Grants may be carried out by government bodies, civil-society organizations, community groups and other approved partners. This structure is intended to combine national ownership with independent oversight, technical review and performance-based financing. Over time, the Global Fund expanded its role from disease-specific financing to broader support for the systems required to deliver effective public health. Its investments have included prevention and testing, medicines and diagnostics, laboratories, health information, procurement, supply chains, community responses and health-workforce capacity. The organization also connects disease programs with efforts to reduce stigma, discrimination and other social conditions that make prevention and treatment less accessible. The Global Fund is financed through voluntary contributions and periodic replenishment efforts. Its stated operating scale is more than US$4 billion raised and invested annually, with activity in more than 100 countries. These resources are intended to complement domestic health spending and other international assistance, while supporting programs that can demonstrate progress against disease and strengthen durable national capabilities. The organization’s present identity combines three related functions: mobilizing international resources, allocating grants through country-led partnerships, and supporting stronger health systems and pandemic preparedness. It remains focused on AIDS, tuberculosis and malaria, but its investments can also improve broader public-health resilience. The Global Fund describes its long-term purpose as ending the epidemics and helping create a healthier, safer and more equitable future.

• 2002

  The Global Fund is established

  [1]Home - The Global Fund to Fight AIDS, Tuberculosis and Malariatheglobalfund.org

  The international financing partnership is established to mobilize and invest resources against AIDS, tuberculosis and malaria.

A multilateral global-health financing partnership focused on measurable progress against AIDS, tuberculosis and malaria, with complementary investments in health systems, equity and pandemic preparedness.

• Global health financing · 2002

  Country and regional grants

  The Global Fund’s core instrument is grant financing for programs in countries and regions heavily affected by HIV/AIDS, tuberculosis and malaria. Grants can support prevention, testing, diagnosis, treatment, care, community-led activities, medicines, diagnostics and implementation infrastructure. Programs are developed through country-led partnerships and implemented by approved public, civil-society and community organizations.

• Health-system strengthening

  Resilient and Sustainable Systems for Health investments

  These investments support capabilities that allow countries to prevent, detect and respond to disease more effectively. Relevant areas may include laboratories, health information, procurement, supply chains, human resources, community systems and pandemic preparedness. The investments complement disease-specific grants and are intended to leave stronger public-health infrastructure in place.

• International fundraising

  Resource mobilization and replenishment partnership

  The Global Fund raises voluntary contributions through a partnership involving governments, foundations, companies, civil-society organizations and other supporters. Periodic replenishment efforts provide a major mechanism for securing multi-year resources for grants and related health investments.

1. 1Home - The Global Fund to Fight AIDS, Tuberculosis and Malariatheglobalfund.org